Evidence map›Paper›PMID 42240636›Full record

ReviewApplied microbiology and biotechnology2026

Engineering of ω-transaminases for advanced applications.

Uwe Wegner, Nicolaus von Wirén, Gotthard Kunze

Abstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Uwe WegnerDepartment of Physiology and Cell Biology, Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Corrensstr. 3, 06466 Seeland, Gatersleben, OT, Germany.
Nicolaus von WirénDepartment of Physiology and Cell Biology, Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Corrensstr. 3, 06466 Seeland, Gatersleben, OT, Germany.
Gotthard KunzeDepartment of Physiology and Cell Biology, Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Corrensstr. 3, 06466 Seeland, Gatersleben, OT, Germany. kunzeg@ipk-gatersleben.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ω-Transaminases (ω-TAs) are well-established biocatalysts for the asymmetric synthesis of chiral amines, yet their broader application remains limited by challenges related to activity, substrate scope, equilibrium constraints in asymmetric synthesis, and process compatibility e.g. solvent tolerance. In recent years, research has shifted from enzyme discovery toward targeted development strategies aimed at addressing these limitations. This review summarizes recent advances in ω-transaminase development, with a focus on protein engineering and process-level optimization. Structure-guided and semi-rational mutagenesis approaches continue to provide robust, incremental improvements, while multi-site, activity-driven engineering has proven effective for challenging substrates such as β- and γ-amino acids or bulky amines. Emerging AI- and AlphaFold-assisted workflows increasingly support rational enzyme design by reducing experimental efforts. Beyond enzyme sequence optimization, reaction engineering, multienzyme cascades, and process intensification strategies play a crucial role in improving overall performance and scalability. Genome mining and discovery efforts are briefly discussed as supporting tools for expanding the ω-transaminase toolbox. Overall, studies in the last years show that successful ω-transaminase development relies more and more on integrated approaches combining enzyme engineering with intelligent process design, rather than on isolated optimization strategies. KEY POINTS: •The state-of-the-art status of ω-TA development is presented. •The shift from enzyme discovery to substrate-based optimization is highlighted. •Modern reaction conditions for more environmentally friendly synthesis are reported.

Indexed as

Protein EngineeringTransaminasesSubstrate SpecificityTransaminasesAI-assisted designEnzyme cascadesMulti-site mutationProtein engineeringRational designω-Transaminases

Identifiers

PMID42240636
PMCPMC13236833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.